← Open Payments lookup

JOHN KAMPHAUS: Open Payments

NPI 1013924257 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$483 in 28 payments from 10 companies in 2025. Trend: 2023 $242 · 2024 $449 · 2025 $483

Food & beverage: $483
CompanyPaymentsAmount
ABBVIE INC.10$159
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$79
Neurocrine BioSciences, Inc.4$70
Takeda Pharmaceuticals U.S.A., Inc.3$57
Otsuka America Pharmaceutical, Inc.2$36
Vanda Pharmaceuticals Inc.1$20
Collegium Pharmaceutical, Inc.1$17
Corium, LLC1$16
Janssen Pharmaceuticals, Inc1$16
Almatica Pharma LLC1$14

Products named: VRAYLAR, CAPLYTA, INGREZZA, TRINTELLIX, REXULTI, FANAPT, Jornay PM, Azstarys.

Industry payments across TX — which companies pay providers there.